+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Autoimmune Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 500 Pages +
  • Global
From
From
From
From
From
From
From
Blockbuster Oncology Brands - Global Strategic Business Report - Product Thumbnail Image

Blockbuster Oncology Brands - Global Strategic Business Report

  • Report
  • August 2026
  • 284 Pages
  • Global
From
From
Urea Cycle Disorder Agent Market - Global Forecast 2026-2032 - Product Thumbnail Image

Urea Cycle Disorder Agent Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
From
Dermatological Drugs - Global Strategic Business Report - Product Thumbnail Image

Dermatological Drugs - Global Strategic Business Report

  • Report
  • August 2026
  • 422 Pages
  • Global
From
Gynecology Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Gynecology Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 100 Pages
  • Global
From
Immunology Market - Global Strategic Business Report - Product Thumbnail Image

Immunology Market - Global Strategic Business Report

  • Report
  • August 2026
  • 374 Pages
  • Global
From
From
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Loading Indicator